MHRA-NICE Pathway Under Fire, Clinical Trial Targets Hit episode artwork

EPISODE · May 27, 2026 · 4 MIN

MHRA-NICE Pathway Under Fire, Clinical Trial Targets Hit

from Carl Haakon's Podcast

Episode 13 — 27 May 2026 LSE expert challenges the new UK aligned drug approval pathway as industry-favoring while EU reports progress on 2030 clinical trial targets. NICE approves first HER2-targeted therapy for bile duct cancer as regulatory reforms reshape the clinical research landscape. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast

Episode metadata supplied by the publisher feed · Published May 27, 2026

Embed this episode

Ready to play

MHRA-NICE Pathway Under Fire, Clinical Trial Targets Hit

0:00 4:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Carl Haakon's Podcast?

This episode is 4 minutes long.

When was this Carl Haakon's Podcast episode published?

This episode was published on May 27, 2026.

Can I download this Carl Haakon's Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!